Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Differential expression of peroxiredoxins in prostate cancer: Consistent upregulation of PRDX3 and PRDX4
Anamika Basu, Hiya Banerjee, Heather Rojas, et al.
The Prostate (2010) Vol. 71, Iss. 7, pp. 755-765
Open Access | Times Cited: 82

Showing 1-25 of 82 citing articles:

Thioredoxins, Glutaredoxins, and Peroxiredoxins—Molecular Mechanisms and Health Significance: from Cofactors to Antioxidants to Redox Signaling
Eva-Maria Hanschmann, José R. Godoy, Carsten Berndt, et al.
Antioxidants and Redox Signaling (2013) Vol. 19, Iss. 13, pp. 1539-1605
Open Access | Times Cited: 621
Peroxiredoxin 1 – an antioxidant enzyme in cancer
Chenbo Ding, Xiaobo Fan, Guoqiu Wu
Journal of Cellular and Molecular Medicine (2016) Vol. 21, Iss. 1, pp. 193-202
Open Access | Times Cited: 183
The role of peroxiredoxins in cancer
Arianna Nicolussi, Sonia D'inzeo, Carlo Capalbo, et al.
Molecular and Clinical Oncology (2017) Vol. 6, Iss. 2, pp. 139-153
Open Access | Times Cited: 164
Roles of peroxiredoxins in cancer, neurodegenerative diseases and inflammatory diseases
Mi Hee Park, Miran Jo, Yu Ri Kim, et al.
Pharmacology & Therapeutics (2016) Vol. 163, pp. 1-23
Open Access | Times Cited: 152
Using Proteomic Approach to Identify Tumor-Associated Proteins as Biomarkers in Human Esophageal Squamous Cell Carcinoma
Jintao Zhang, Kaijuan Wang, Jianzhong Zhang, et al.
Journal of Proteome Research (2011) Vol. 10, Iss. 6, pp. 2863-2872
Open Access | Times Cited: 135
Tissue‐based proteomics reveals FXYD3, S100A11 and GSTM3 as novel markers for regional lymph node metastasis in colon cancer
Stephan Meding, Benjamin Balluff, Mareike Elsner, et al.
The Journal of Pathology (2012) Vol. 228, Iss. 4, pp. 459-470
Closed Access | Times Cited: 129
New insights into the roles of peroxiredoxins in cancer
Yan Liu, Pu Wang, Weina Hu, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 164, pp. 114896-114896
Open Access | Times Cited: 27
Implications and progression of peroxiredoxin 2 (PRDX2) in various human diseases
Priyanka Balasubramanian, Varshini Vijayarangam, Mangayer karasi Gopalakrishnan Deviparasakthi, et al.
Pathology - Research and Practice (2024) Vol. 254, pp. 155080-155080
Closed Access | Times Cited: 8
Peroxiredoxin-3 is overexpressed in prostate cancer and promotes cancer cell survival by protecting cells from oxidative stress
Hayley C. Whitaker, Divya Patel, William Howat, et al.
British Journal of Cancer (2013) Vol. 109, Iss. 4, pp. 983-993
Open Access | Times Cited: 96
Exosomal Release of L-Plastin by Breast Cancer Cells Facilitates Metastatic Bone Osteolysis
Kerstin Tiedemann, Gulzhakhan Sadvakassova, Nicholas Mikolajewicz, et al.
Translational Oncology (2018) Vol. 12, Iss. 3, pp. 462-474
Open Access | Times Cited: 75
Peroxiredoxin Involvement in the Initiation and Progression of Human Cancer
Mark B. Hampton, Kate Angela Vick, John Skoko, et al.
Antioxidants and Redox Signaling (2017) Vol. 28, Iss. 7, pp. 591-608
Open Access | Times Cited: 67
Drosophila Jak/STAT Signaling: Regulation and Relevance in Human Cancer and Metastasis
Sunny Trivedi, Michelle Starz‐Gaiano
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 12, pp. 4056-4056
Open Access | Times Cited: 63
Statistical Considerations of Optimal Study Design for Human Plasma Proteomics and Biomarker Discovery
Cong Zhou, Kathryn Simpson, Lee Lancashire, et al.
Journal of Proteome Research (2012) Vol. 11, Iss. 4, pp. 2103-2113
Open Access | Times Cited: 65
Expression of the Stress Response Oncoprotein LEDGF/p75 in Human Cancer: A Study of 21 Tumor Types
Anamika Basu, Heather Rojas, Hiya Banerjee, et al.
PLoS ONE (2012) Vol. 7, Iss. 1, pp. e30132-e30132
Open Access | Times Cited: 62
Peroxiredoxin 3 Is a Redox-Dependent Target of Thiostrepton in Malignant Mesothelioma Cells
Kheng Newick, Brian Cunniff, Kelsey Preston, et al.
PLoS ONE (2012) Vol. 7, Iss. 6, pp. e39404-e39404
Open Access | Times Cited: 62
New Challenges to Study Heterogeneity in Cancer Redox Metabolism
Rui Benfeitas, Mathias Uhlén, Jens Nielsen, et al.
Frontiers in Cell and Developmental Biology (2017) Vol. 5
Open Access | Times Cited: 60
Disruption of the c-Myc/miR-200b-3p/PRDX2 regulatory loop enhances tumor metastasis and chemotherapeutic resistance in colorectal cancer
Zhenbing Lv, Jinlai Wei, Wenxian You, et al.
Journal of Translational Medicine (2017) Vol. 15, Iss. 1
Open Access | Times Cited: 58
Selenium- or Vitamin E–Related Gene Variants, Interaction with Supplementation, and Risk of High-Grade Prostate Cancer in SELECT
June M. Chan, Amy K. Darke, Kathryn L. Penney, et al.
Cancer Epidemiology Biomarkers & Prevention (2016) Vol. 25, Iss. 7, pp. 1050-1058
Open Access | Times Cited: 57
Physiological and pathological views of peroxiredoxin 4
Junichi Fujii, Yoshitaka Ikeda, Toshihiro Kurahashi, et al.
Free Radical Biology and Medicine (2015) Vol. 83, pp. 373-379
Closed Access | Times Cited: 55
Liver proteome response of pre-harvest Atlantic salmon following exposure to elevated temperature
Waldo G. Nuez‐Ortín, CG Carter, Peter D. Nichols, et al.
BMC Genomics (2018) Vol. 19, Iss. 1
Open Access | Times Cited: 54
Peroxiredoxins in Cancer and Response to Radiation Therapies
Tom E. Forshaw, Reetta Holmila, Kimberly Nelson, et al.
Antioxidants (2019) Vol. 8, Iss. 1, pp. 11-11
Open Access | Times Cited: 48
PRDX4 and Its Roles in Various Cancers
Wenqiao Jia, Pengxiang Chen, Yufeng Cheng
Technology in Cancer Research & Treatment (2019) Vol. 18
Open Access | Times Cited: 45
The Role of Peroxiredoxin Family in Cancer Signaling
Yosup Kim, Ho Hee Jang
Journal of Cancer Prevention (2019) Vol. 24, Iss. 2, pp. 65-71
Open Access | Times Cited: 44
Critical Role of the Sulfiredoxin-Peroxiredoxin IV Axis in Urethane-Induced Non-Small Cell Lung Cancer
Yanning Hao, Hong Jiang, Pratik Thapa, et al.
Antioxidants (2023) Vol. 12, Iss. 2, pp. 367-367
Open Access | Times Cited: 13
Peroxiredoxins 3 and 4 Are Overexpressed in Prostate Cancer Tissue and Affect the Proliferation of Prostate Cancer Cells in Vitro
Ramesh Ummanni, Frederico Barreto, Simone Venz, et al.
Journal of Proteome Research (2012) Vol. 11, Iss. 4, pp. 2452-2466
Closed Access | Times Cited: 54
Page 1 - Next Page

Scroll to top